BRPI1010256A2 - "aplicações terapêuticas no domínio cardiovascular de derivados de quinazolina diona." - Google Patents

"aplicações terapêuticas no domínio cardiovascular de derivados de quinazolina diona."

Info

Publication number
BRPI1010256A2
BRPI1010256A2 BRPI1010256A BRPI1010256A BRPI1010256A2 BR PI1010256 A2 BRPI1010256 A2 BR PI1010256A2 BR PI1010256 A BRPI1010256 A BR PI1010256A BR PI1010256 A BRPI1010256 A BR PI1010256A BR PI1010256 A2 BRPI1010256 A2 BR PI1010256A2
Authority
BR
Brazil
Prior art keywords
therapeutic applications
dione derivatives
cardiovascular field
quinazoline dione
quinazoline
Prior art date
Application number
BRPI1010256A
Other languages
English (en)
Inventor
Fabrice Viviani
Gilbert Marciniak
Jean-François Nave
Philip Janiak
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI1010256A2 publication Critical patent/BRPI1010256A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1010256A 2009-04-09 2010-04-07 "aplicações terapêuticas no domínio cardiovascular de derivados de quinazolina diona." BRPI1010256A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901755A FR2944206B1 (fr) 2009-04-09 2009-04-09 Applications therapeutiques dans le domaine cardiovasculaire de derives de quinazolinedione
PCT/FR2010/050672 WO2010116090A1 (fr) 2009-04-09 2010-04-07 Applications thérapeutiques dans le domaine cardiovasculaire de dérivés de quinazolinedione

Publications (1)

Publication Number Publication Date
BRPI1010256A2 true BRPI1010256A2 (pt) 2016-03-22

Family

ID=41181038

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010256A BRPI1010256A2 (pt) 2009-04-09 2010-04-07 "aplicações terapêuticas no domínio cardiovascular de derivados de quinazolina diona."

Country Status (35)

Country Link
US (1) US8846654B2 (pt)
EP (1) EP2416777B1 (pt)
JP (1) JP5685578B2 (pt)
KR (1) KR101686267B1 (pt)
CN (1) CN102458409B (pt)
AR (1) AR076232A1 (pt)
AU (1) AU2010233596B2 (pt)
BR (1) BRPI1010256A2 (pt)
CA (1) CA2758234A1 (pt)
CL (1) CL2011002525A1 (pt)
CO (1) CO6440577A2 (pt)
CR (1) CR20110527A (pt)
CY (1) CY1115987T1 (pt)
DK (1) DK2416777T3 (pt)
DO (1) DOP2011000306A (pt)
EA (1) EA020984B1 (pt)
EC (1) ECSP11011377A (pt)
ES (1) ES2528633T3 (pt)
FR (1) FR2944206B1 (pt)
HK (1) HK1165997A1 (pt)
HR (1) HRP20150106T1 (pt)
HU (1) HUE024161T2 (pt)
IL (1) IL215610A (pt)
MA (1) MA33254B1 (pt)
MX (1) MX2011010645A (pt)
NI (1) NI201100180A (pt)
NZ (1) NZ595660A (pt)
PL (1) PL2416777T3 (pt)
PT (1) PT2416777E (pt)
SG (2) SG10201400420PA (pt)
SI (1) SI2416777T1 (pt)
TN (1) TN2011000506A1 (pt)
TW (1) TWI457330B (pt)
UY (1) UY32555A (pt)
WO (1) WO2010116090A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944282B1 (fr) * 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
EP2854780B1 (en) 2012-06-05 2017-08-30 University Of Kansas Inhibitors of respiratory syncytial virus
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
WO2024038089A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879393A (en) * 1973-06-18 1975-04-22 Miles Lab Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones
JPS56164172A (en) * 1980-05-22 1981-12-17 Masayuki Ishikawa Novel 2,4 1h,3h -quinazolinedione derivative
EP0040793B1 (en) * 1980-05-22 1985-08-28 Masayuki Ishikawa Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
EP0638567A4 (en) 1993-02-18 1995-05-10 Kyowa Hakko Kogyo Kk ADENOSINE INHIBITORS.
CA2328413A1 (en) 1998-04-20 1999-10-28 Fujisawa Pharmaceutical Co., Ltd. Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
AU2525701A (en) 1999-12-14 2001-06-25 Sanofi-Synthelabo Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
CA2599662A1 (en) 2005-03-01 2006-09-08 Pfizer Limited Use of pde7 inhibitors for the treatment of neuropathic pain
WO2006092692A1 (en) 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
WO2007067946A2 (en) 2005-12-07 2007-06-14 The Regents Of The University Of California Diagnosis and treatment of chronic lymphocytic leukemia (cll)
AU2008230710B2 (en) 2007-03-27 2014-04-10 Omeros Corporation The use of PDE7 inhibitors for the treatment of movement disorders
WO2008133155A1 (ja) 2007-04-19 2008-11-06 Astellas Pharma Inc. 二環式ヘテロ環化合物
FR2921926B1 (fr) * 2007-10-03 2009-12-04 Sanofi Aventis Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione

Also Published As

Publication number Publication date
WO2010116090A1 (fr) 2010-10-14
IL215610A0 (en) 2011-12-29
CN102458409A (zh) 2012-05-16
NI201100180A (es) 2012-01-11
UY32555A (es) 2010-11-30
US20120184522A1 (en) 2012-07-19
CL2011002525A1 (es) 2012-02-17
CR20110527A (es) 2014-05-12
CA2758234A1 (fr) 2010-10-14
SG10201400420PA (en) 2014-05-29
EP2416777A1 (fr) 2012-02-15
AU2010233596A1 (en) 2011-11-03
US8846654B2 (en) 2014-09-30
HRP20150106T1 (hr) 2015-05-08
MX2011010645A (es) 2012-01-19
EA020984B1 (ru) 2015-03-31
NZ595660A (en) 2013-03-28
KR20120005499A (ko) 2012-01-16
JP5685578B2 (ja) 2015-03-18
TW201040155A (en) 2010-11-16
DK2416777T3 (en) 2015-02-09
SG175131A1 (en) 2011-11-28
PT2416777E (pt) 2015-02-04
TN2011000506A1 (fr) 2013-05-24
ECSP11011377A (es) 2011-11-30
PL2416777T3 (pl) 2015-05-29
SI2416777T1 (sl) 2015-02-27
CN102458409B (zh) 2014-06-18
CO6440577A2 (es) 2012-05-15
HK1165997A1 (en) 2012-10-19
IL215610A (en) 2013-07-31
ES2528633T3 (es) 2015-02-11
TWI457330B (zh) 2014-10-21
MA33254B1 (fr) 2012-05-02
FR2944206B1 (fr) 2012-12-28
EP2416777B1 (fr) 2014-11-12
EA201171229A1 (ru) 2012-12-28
CY1115987T1 (el) 2017-01-25
FR2944206A1 (fr) 2010-10-15
DOP2011000306A (es) 2011-10-31
HUE024161T2 (hu) 2016-02-29
KR101686267B1 (ko) 2016-12-13
AU2010233596B2 (en) 2016-06-23
JP2012523398A (ja) 2012-10-04
AR076232A1 (es) 2011-05-26

Similar Documents

Publication Publication Date Title
BR112013015592A8 (pt) derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BRPI1010882A2 (pt) derivados de triazina e suas aplicações terapêuticas.
BRPI0809795A2 (pt) "antagonistas do trpv1 e usos deste".
BRPI1015967A2 (pt) "unidade de dobradiça, e, peça de mobília."
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
ZA201107363B (en) Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
FR2939766B1 (fr) Pylone central d'aeronef.
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
BRPI1010256A2 (pt) "aplicações terapêuticas no domínio cardiovascular de derivados de quinazolina diona."
BRPI1012325A2 (pt) uso de microrna-199b-5p no campo médico e diagnóstico."
FI20065456L (fi) Maitotuotteiden rakenteen parantaminen
IT1400116B1 (it) Composizione fotoattiva ad elevata mobilita' delle lacune elettroniche.
BRPI0813187A2 (pt) 13-hidroperóxido liases modificadas e respectivos usos.
FI20085333L (fi) Aktuaattorin äänikentän suuntaaminen
FI20070857A (fi) Kappaleen pinnoitus
FR2952798B1 (fr) Agencement d'une douche integrale et autonome, temporaire
IT1396036B1 (it) Configurazione strutturale di campo cimiteriale
IT1390958B1 (it) Schiaccianoci ad elevata funzionalita' di impiego.
Green Of Theatre: Its Production and Reception
TH101898B (th) กระดาน
TH90233B (th) บาสเก็ตบอล
ITLE20090012U1 (it) Il pasto di enea.
GB0821489D0 (en) The medicinal uses of molecules and their derivatives
TH114523B (th) องค์ประกอบทำให้หอม และ การใช้ของสิ่งเหล่านั้น

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]